Invention Grant
- Patent Title: Adjuvant incorporation in immunoanotherapeutics
- Patent Title (中): 佐剂掺入免疫治疗
-
Application No.: US14084424Application Date: 2013-11-19
-
Publication No.: US09439859B2Publication Date: 2016-09-13
- Inventor: Frank Alexis , Matteo Iannacone , Jinjun Shi , Pamela Basto , Elliott Ashley Moseman , Ulrich von Andrian , Robert S. Langer , Omid C. Farokhzad , Elena Tonti
- Applicant: Massachusetts Institute of Technology , The Brigham and Women's Hospital, Inc. , President and Fellows of Harvard College
- Applicant Address: US MA Cambridge US MA Boston US MA Boston
- Assignee: Massachusetts Institute of Technology,The Brigham and Women's Hospital, Inc.,Presidents and Fellows of Harvard College
- Current Assignee: Massachusetts Institute of Technology,The Brigham and Women's Hospital, Inc.,Presidents and Fellows of Harvard College
- Current Assignee Address: US MA Cambridge US MA Boston US MA Boston
- Agency: Pabst Patent Group LLP
- Main IPC: A61K9/14
- IPC: A61K9/14 ; A61K9/16 ; A61K36/14 ; A61K51/00 ; A61K39/00 ; A61K39/39 ; A61K45/06 ; A61K38/20 ; A61K38/21 ; A61K39/002 ; A61K39/05 ; A61K39/08 ; A61K39/12
Abstract:
The present invention provides compositions and systems for delivery of nanocarriers to cells of the immune system. The invention provides nanocarriers capable of stimulating an immune response in T cells and/or in B cells. The invention provides nanocarriers that comprise an immunofeature surface and an immunostimulatory moiety. In some embodiments, the immunostimulatory moiety is adjuvant. The invention provides pharmaceutical compositions comprising inventive nanocarriers. The present invention provides methods of designing, manufacturing, and using inventive nanocarriers and pharmaceutical compositions thereof.
Public/Granted literature
- US20140127301A1 Adjuvant Incorporation in Immunonanotherapeutics Public/Granted day:2014-05-08
Information query
